The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention
Standard treatment for Glanzmann thrombasthenia, a severe inherited bleeding disorder, is platelet transfusion. Recombinant factor VIIa is reported to be effective in Glanzmann thrombasthenia with platelet antibodies and/or refractoriness to platelet transfusions. We aimed to evaluate recombinant fa...
| Published in: | Haematologica |
|---|---|
| Main Authors: | , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2015-08-01
|
| Online Access: | https://haematologica.org/article/view/7460 |
